Lasofoxifene is a third-generation selective estrogen receptor modulator (SERM) that acts as an agonist in bone tissue and an antagonist in breast and uterine tissue, primarily indicated for the treatment… Read more








Lasofoxifene is a third-generation selective estrogen receptor modulator (SERM) that acts as an agonist in bone tissue and an antagonist in breast and uterine tissue, primarily indicated for the treatment of postmenopausal osteoporosis by inhibiting bone resorption. This category provides essential reference standards, including the active pharmaceutical ingredient, to support rigorous impurity profiling and analytical testing. Pharmaceutical laboratories utilize these high-quality materials for method validation and quality control procedures, ensuring accurate identification and quantification of related substances. The collection includes pharmacopeial and non-pharmacopeial impurities, such as process-related degradants like N-(2-hydroxyethyl)pyrrolidine, alongside key metabolites, including the 2-oxide derivative, glucuronides, and sulfates. Additionally, stable isotope labelled compounds are available, serving as critical internal standards in mass spectrometry-based assays to facilitate precise pharmacokinetic studies and the monitoring of drug metabolism.